Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Numinus Wellness Inc.
  6. Summary
    NUMI   CA67054W1032

NUMINUS WELLNESS INC.

(NUMI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Bourse De Toronto
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
0.82(c) 0.77(c) 0.84(c) 0.84(c) 0.83 Last
454 769 307 839 1 206 192 196 997 366 229 Volume
+1.23% -6.10% +9.09% 0.00% -1.19% Change
More quotes
Estimated financial data (e)
Sales 2021 2,00 M 1,57 M 1,57 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 9,50 M 7,43 M 7,43 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 171 M 133 M 133 M
Capi. / Sales 2021 85,3x
Capi. / Sales 2022 17,9x
Nbr of Employees -
Free-Float 94,5%
More Financials
Company
Numinus Wellness Inc. (Numinus) is a Canada-based health care company focused on creating an ecosystem of wellness solutions through access, research, training and therapies centered on psychedelic therapies. The Company, through its subsidiary Salvation Botanicals Ltd, has a Health Canada cannabis testing license and dealer’s license. The testing license allows the Company to test and analyze cannabis products... 
Read more
Sector
Biotechnology & Medical Research
Calendar
09/27 | 02:00pmPresentation
More about the company
All news about NUMINUS WELLNESS INC.
09/02NUMINUS WELLNESS : to Participate in Upcoming Investor Conferences in September 2021
AQ
07/29NUMINUS WELLNESS : Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances..
PR
07/29Numinus Wellness Inc. Announces Consolidated Earnings Results for the Third Quarter and..
CI
07/12NUMINUS WELLNESS : Announces up 11% as Health Canada Approves Open Label Study for MDMA-As..
MT
07/12NUMINUS WELLNESS : Announces Health Canada Approval of MAPS-Sponsored Open Label Study for..
PR
07/12Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-As..
CI
07/06NUMINUS WELLNESS : To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psyc..
PR
07/06Numinus Wellness to Acquire Neurology Centre of Toronto, Plans to Create Centre for Psy..
CI
07/06Evan Lewis to Join Numinus Wellness Inc. as VP, Psychedelic Neurology Services
CI
07/06Numinus Wellness Inc. agreed to acquire the Neurology Centre of Toronto for CAD 0.1 mil..
CI
06/24NUMINUS WELLNESS : Announces Grant of Stock Options
AQ
06/24NUMINUS WELLNESS : Files U.S. Provisional Patent Application for a Proprietary Rapid Produ..
PR
06/18NUMINUS WELLNESS : Granted Tier 1 Issuer Status on TSX Venture Exchange; Rose 2.9% on Thur..
MT
06/18NUMINUS WELLNESS : Graduates to Tier 1 on the TSX Venture Exchange
PR
06/15Optimi Health and Numinus Wellness Inc. Completes Pre-Clinical Trial Application Meetin..
CI
More news
News in other languages on NUMINUS WELLNESS INC.

- No features available -

More news
Chart NUMINUS WELLNESS INC.
Duration : Period :
Numinus Wellness Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,84 CAD
Average target price 1,10 CAD
Spread / Average Target 31,0%
Managers and Directors
Payton Nyquvest Chairman, President & Chief Executive Officer
John Fong Chief Financial Officer & Secretary
Evan Wood Chief Medical Officer
Devon Christie Medical Director
Sharan Sindhu Science Officer & General Manager
Sector and Competitors
1st jan.Capi. (M$)
NUMINUS WELLNESS INC.-21.50%133
MODERNA, INC.315.47%170 876
LONZA GROUP AG31.58%59 927
IQVIA HOLDINGS INC.43.03%48 510
CELLTRION, INC.-23.26%31 691
SEAGEN INC.-5.78%28 939